Cancers · 2025 · 10 citations · 23 references
MedicineImmunologyOncologyCancer ImmunologyTumor ImmunologyTumor MicroenvironmentCancer ImmunosurveillanceCancer ImmunotherapyImmunotherapy For Solid TumorsTumor Immune MicroenvironmentTumor ImmunopathologyTumor-associated MacrophagesCancer-associated ImmunosuppressionCancer-associated MacrophagesImmunofluorescence AssaysImmunosuppressive MicroenvironmentM2 Macrophage PhenotypesMer Receptor Tyrosine Kinase SignalingMertk SignalingTumor-associated Macrophage Polarization
Background: A hallmark of cancer is the presence of an immunosuppressive tumor microenvironment (TME). Immunosuppressive M2 macrophages (MΦs) in the TME facilitate escape from immune surveillance and promote tumor growth; therefore, TME-induced immunosuppression is a potent immunotherapeutic approach to treating cancer. Methods: Cancer cell-secreted proteins were detected by using liquid chromatography–mass spectrometry (LC-MS). Neutralizing antibodies (nAbs) were used to assess which proteins were involved in MΦs polarization and differentiation. The protein–protein interaction was characterized using co-immunoprecipitation and immunofluorescence assays. Cancer-secreted heat shock protein 70 (Hsp70) protein was quantified using an enzyme-linked immunosorbent assay (ELISA). MΦ polarization and tumor growth were assessed in vivo with subcutaneous LLC-GFP tumor models and toll-like receptor 2 (TLR2) knockout mice; in vitro assessments were conducted using TLR2 knockout and both LLC-GFP and LN227 lentiviral-mediated knockdown (KD) cells. Results: Cancer cells released a secreted form of Hsp70 that acted on MΦ TLR2 to upregulate Mer receptor tyrosine kinase (MerTK) and induce MΦ M2 polarization. Hsp70 nAbs led to a reduction in CD14 expression by 75% in THP-1 cells in response to Gli36 EMD-CM. In addition, neutralizing TLR2 nAbs resulted in a 30% and 50% reduction in CD14 expression on THP-1 cells in response to MiaPaCa-2 and Gli36 exosome/microparticle-depleted conditioned media (EMD-CMs), respectively. Hsp70, TLR2, and MerTK formed a protein complex. Tumor growth and intra-tumor M2 MΦs were significantly reduced upon cancer cell Hsp70 knockdown and in TLR2 knockout mice. Conclusions: Cancer-secreted Hsp70 interacts with TLR2, upregulates MerTK on MΦs, and induces immunosuppressive MΦ M2 polarization. This previously unreported action of secreted Hsp70 suggests that disrupting the Hsp70-TLR2-MerTK interaction could serve as a promising immunotherapeutic approach to mitigate TME immunosuppression in solid cancers.
23
TLR signalling augments macrophage bactericidal activity through mitochondrial ROS
A. Phillip West, Igor E. Brodsky, Christoph Rahner et al. · Nature · 2011 · 1.6K citations · Full text
Novel Signal Transduction Pathway Utilized by Extracellular HSP70
Alexzander Asea, Michael Rehli, Edith Kabingu et al. · Journal of Biological Chemistry · 2002 · 1.5K citations · Full text
Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis
Sun-Hwa Kim, Hiroyuki Takahashi, Wan‐Wan Lin et al. · Nature · 2008 · 1.1K citations · Full text
Medicine, Immunology, Oncology +13
Role of Macrophage Targeting in the Antitumor Activity of Trabectedin
Giovanni Germano, Roberta Frapolli, Cristina Belgiovine et al. · Cancer Cell · 2013 · 862 citations · Full text
Life Sciences, Immunology, Oncology +14